Csenge Advisory Group’s Zimmer Biomet ZBH Stock Holding History

Csenge Advisory Group’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-99	Closed	-$10K	–	1535
2018 Q3	$10K	Buy	+99	New	+$11.8K	﹤0.01%	519

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Csenge Advisory Group's ZBH Position: Q4 2018 in Review

Csenge Advisory Group sold out of Zimmer Biomet (ZBH) in Q4 2018, closing a stake of 99 shares — an estimated $10K sold.

Csenge Advisory Group first reported a position in ZBH in Q3 2018 and held it in 1 quarter. The position peaked at $10K in Q3 2018. 871 funds tracked by Wall St. Rank hold ZBH as of Q4 2018.

Csenge Advisory Group reported no remaining Zimmer Biomet position as of Q4 2018 after selling out during the quarter.
Csenge Advisory Group sold 99 Zimmer Biomet shares in Q4 2018, an estimated $10K.
Csenge Advisory Group first reported a position in Zimmer Biomet in Q3 2018 and held it in 1 quarter.
Csenge Advisory Group's Zimmer Biomet position peaked at $10K in Q3 2018.
871 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2018.

Based on Csenge Advisory Group's 13F filing for Q4 2018, filed 7 Feb 2019.